---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-26-000846"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2026-03-12T23:59:59+00:00"
generated_at: "2026-05-15T12:59:23.901130+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# IGC Pharma issues $353K convertible note to Vanquish Funding; also obtains $219K loan

## Summary
- Principal $353,050 includes $46,050 original issue discount; net proceeds $307,000 for working capital.
- Upon default, holder can convert at 75% of lowest 10-day trading price, subject to 4.99% ownership cap.
- Additional tranche up to $2,015,000 over 12 months available subject to further agreement.
- Separate loan from One Deck Capital of ~$219,000 with scheduled periodic payments for general corporate purposes.
- Conversion capped at 19.99% of outstanding shares without shareholder approval per NYSE American rules.

## SEC filing metadata
- accession: 0001185185-26-000846
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2026-03-12T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000846/0001185185-26-000846-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000846/igc8k031126.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-26-000846
- JSON: https://secwatch.observer/filing/0001185185-26-000846.json
- Plain text: https://secwatch.observer/filing/0001185185-26-000846.txt

## Source-grounded claims
- claim_id: 8c21144fb524fac8905b4348dc7b798e5664d375
  claim: IGC Pharma, Inc. incurred loan of approximately $219,000 with One Deck Capital, Inc..
  evidence_excerpt: The Company entered into a loan agreement with One Deck Capital, Inc. (“One Deck”), pursuant to which the Company received approximately $219,000 in financing (the “One Deck Loan”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000846/0001185185-26-000846-index.htm
- claim_id: f792a150e36b3d99bca7dddd2bbe34b73c71516f
  claim: IGC Pharma, Inc. incurred loan of $353,050 with Vanquish Funding Group Inc. maturing February 28, 2027.
  evidence_excerpt: On March 5, 2026, IGC Pharma, Inc. (“IGC” or the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Vanquish Funding Group Inc.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000846/0001185185-26-000846-index.htm
- claim_id: 2de73be36294ea789191c9372ff1773b49042400
  claim: IGC Pharma, Inc. entered into a credit facility with One Deck Capital, Inc. valued at approximately $219,000.
  evidence_excerpt: The Company entered into a loan agreement with One Deck Capital, Inc. (“One Deck”), pursuant to which the Company received approximately $219,000 in financing (the “One Deck Loan”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000846/0001185185-26-000846-index.htm
- claim_id: 5ef167f48d312eabbe87e0890daeb135fba57074
  claim: IGC Pharma, Inc. entered into Securities Purchase Agreement with Vanquish Funding Group Inc. (effective 2026-03-05).
  evidence_excerpt: On March 5, 2026, IGC Pharma, Inc. (“IGC” or the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with Vanquish Funding Group Inc., a Virginia corporation (“VFG” or the “Holder”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000846/0001185185-26-000846-index.htm
- claim_id: 643665474c4ccdbc18a4c1f792f06047c8b5455a
  claim: IGC Pharma, Inc. entered into Promissory Note with Vanquish Funding Group Inc. valued at $353,050 (effective 2026-03-05).
  evidence_excerpt: Pursuant to the terms of the Purchase Agreement, the Company issued a Promissory Note (the “Note”) to VFG with a total principal amount of $353,050
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518526000846/0001185185-26-000846-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.